Sign Up to like & get recommendations! 1
Published in 2018 at "Modern Pathology"
DOI: 10.1038/modpathol.2017.132
Abstract: Primary mucinous tumors and secondary tumors involving the prostate gland are relatively uncommon, however they have important diagnostic, therapeutic, and prognostic implications. The primary mucinous tumors of the prostate include mucinous (colloid) adenocarcinoma of the… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Cancer Investigation"
DOI: 10.1080/07357907.2021.2019263
Abstract: Abstract In this study, we evaluated the association of ISUP/WHO-grade groups with various pathological prognostic parameters and cancer-specific survival in patients with prostatic adenocarcinoma. We found 27 (15.7%) cases of grade group 1, 22 (12.8%)… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "American Journal of Clinical Pathology"
DOI: 10.1093/ajcp/aqaa161.128
Abstract: CDX2 encodes a transcription factor expressed in the nuclei of intestinal epithelial cells. The CDX2 immunohistochemical stain has excellent diagnostic utility in the setting of carcinoma of unknown primary, especially in combination with cytokeratins 7… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000002254
Abstract: We report the case of a 69-year-old man referred for F-fluorocholine (FCH) PET/CT for a biochemical recurrence of prostate cancer. FCH PET/CT demonstrated 2 hypodense hepatic lesions with no uptake but progressing in size compared… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000004387
Abstract: ABSTRACT A 64-year-old man with a history of Gleason 7 (3 + 4) pT2cN0 prostatic adenocarcinoma status post prostatectomy underwent a fluciclovine PET/CT that showed a tracer-avid right upper lobe spiculated solitary pulmonary nodule. Follow-up… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "BMJ Case Reports"
DOI: 10.1136/bcr-2019-230899
Abstract: Malignant ascites in prostatic acinar adenocarcinoma is very rare. We present an 84-year-old man with a rare malignant ascites due to prostatic adenocarcinoma demonstrating hepatoid differentiation by immunohistochemistry. The patient was diagnosed with the malignant… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-4518
Abstract: INTRODUCTION: Prostate cancer is the second most common type of cancer in men worldwide. Despite this, screening is currently disputed because studies in the western world have shown that more men die with the disease… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.e17006
Abstract: e17006 Background: Prostate cancer is the most commonly diagnosed cancer in men, affecting 1 in 8 men in the United States in their lifetime. Adenocarcinoma is the most common subtype of prostate cancer representing >… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Medicine and Life"
DOI: 10.25122/jml-2021-0272
Abstract: Prostatic adenocarcinoma is the second-most common cancer in men and the fifth most common cause of cancer death. Its incidence increases with age; 75% of patients are 65 years and older. The aim of the… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Molecular Imaging and Radionuclide Therapy"
DOI: 10.4274/mirt.galenos.2024.76259
Abstract: ABSTRACT Prostatic adenocarcinoma is characterized by elevated phosphatidylcholine metabolism. 18F-choline positron emission tomography/computed tomography (PET/CT) is widely used for patients with biochemical recurrence and a prostate-specific antigen threshold above 2 ng/mL. We report a case… read more here.